PT90466A - Processo de preparacao de composicoes farmaceuticas compreendendo um excipiente extragranular, higroscopio insoluvel em agua e um ingrediente activo, em particular a cimetidina - Google Patents

Processo de preparacao de composicoes farmaceuticas compreendendo um excipiente extragranular, higroscopio insoluvel em agua e um ingrediente activo, em particular a cimetidina

Info

Publication number
PT90466A
PT90466A PT90466A PT9046689A PT90466A PT 90466 A PT90466 A PT 90466A PT 90466 A PT90466 A PT 90466A PT 9046689 A PT9046689 A PT 9046689A PT 90466 A PT90466 A PT 90466A
Authority
PT
Portugal
Prior art keywords
insoluble
water
hygroscope
active ingredient
pharmaceutical compositions
Prior art date
Application number
PT90466A
Other languages
English (en)
Other versions
PT90466B (pt
Inventor
Gordon France
Graham Stanley Leonard
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP88304008A external-priority patent/EP0294933B1/en
Priority claimed from GB888820265A external-priority patent/GB8820265D0/en
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of PT90466A publication Critical patent/PT90466A/pt
Publication of PT90466B publication Critical patent/PT90466B/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT90466A 1988-05-04 1989-05-04 Processo de preparacao de composicoes farmaceuticas compreendendo um excipiente extragranular, higroscopio insoluvel em agua e um ingrediente activo, em particular a cimetidina PT90466B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP88304008A EP0294933B1 (en) 1987-05-08 1988-05-04 Pharmaceutical compositions
GB888820265A GB8820265D0 (en) 1988-08-26 1988-08-26 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
PT90466A true PT90466A (pt) 1989-11-30
PT90466B PT90466B (pt) 1994-08-31

Family

ID=26116144

Family Applications (1)

Application Number Title Priority Date Filing Date
PT90466A PT90466B (pt) 1988-05-04 1989-05-04 Processo de preparacao de composicoes farmaceuticas compreendendo um excipiente extragranular, higroscopio insoluvel em agua e um ingrediente activo, em particular a cimetidina

Country Status (14)

Country Link
EP (1) EP0349103B1 (pt)
JP (1) JP2635407B2 (pt)
KR (1) KR890016963A (pt)
AT (1) ATE82680T1 (pt)
AU (1) AU620866B2 (pt)
DE (1) DE68903605T2 (pt)
DK (1) DK214689A (pt)
ES (1) ES2052911T3 (pt)
GR (1) GR3006498T3 (pt)
IE (1) IE62728B1 (pt)
MY (1) MY104010A (pt)
NZ (1) NZ228970A (pt)
PH (1) PH25173A (pt)
PT (1) PT90466B (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8730011D0 (en) * 1987-12-23 1988-02-03 Smithkline Dauelsberg Pharmaceutical compositions
US5260072A (en) * 1990-08-30 1993-11-09 Mcneil-Ppc, Inc. Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
CA2052679C (en) * 1990-08-30 1997-12-02 Edward J. Roche Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
ATE217789T1 (de) * 1992-06-04 2002-06-15 Smithkline Beecham Corp Angenehm schmeckende pharmazeutische zusammensetzungen
GB9221414D0 (en) * 1992-10-13 1992-11-25 Glaxo Group Ltd Pharmaceutical compositions
HUT72408A (en) * 1993-09-10 1996-04-29 Egyt Gyogyszervegyeszeti Gyar Process for producing tablets containing acetyl-salicylic acid
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
CA2258159C (en) * 1996-06-14 2006-03-21 Kyowa Hakko Kogyo Co., Ltd. Intraorally rapidly disintegrable tablet
US6537525B1 (en) * 1997-01-29 2003-03-25 Douglas H. West Medicated chewing-gum
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
CA2305179A1 (en) * 1997-09-30 1999-04-08 Daiichi Pharmaceutical Co., Ltd. Oral administration preparation
US7842308B2 (en) 2001-01-30 2010-11-30 Smithkline Beecham Limited Pharmaceutical formulation
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
JP2004107258A (ja) * 2002-09-18 2004-04-08 Ss Pharmaceut Co Ltd 催眠用圧縮成型製剤
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
AU2005299490C1 (en) 2004-10-21 2012-01-19 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
JP2006342188A (ja) 2006-09-28 2006-12-21 Rohto Pharmaceut Co Ltd 口中溶解型又は咀嚼型鼻炎治療用固形内服医薬組成物
KR101765357B1 (ko) 2009-12-02 2017-08-04 아데어 파마수티컬스 에스.알.엘. 펙소페나딘 마이크로캡슐 및 그것을 함유하는 조성물
JP2013032408A (ja) * 2012-11-22 2013-02-14 Rohto Pharmaceutical Co Ltd 口中溶解型又は咀嚼型鼻炎治療用固形内服医薬組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES412146A1 (es) * 1972-03-11 1976-01-01 Pfizer Procedimiento de obtencion de composiciones para reducir elhabito del tabaco.
NL7311319A (pt) * 1972-09-01 1974-03-05
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
CA1229552A (en) * 1984-07-09 1987-11-24 Audley A. Legore Cimetidine compositions
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
KR960011236B1 (ko) * 1987-05-08 1996-08-21 스미스 클라인 앤드 프렌취 라보라토리스 리미티드 제약학적 조성물 및 고체 제형

Also Published As

Publication number Publication date
MY104010A (en) 1993-10-30
DE68903605D1 (de) 1993-01-07
PH25173A (en) 1991-03-27
JP2635407B2 (ja) 1997-07-30
ES2052911T3 (es) 1994-07-16
IE62728B1 (en) 1995-02-22
DK214689A (da) 1989-11-05
DK214689D0 (da) 1989-05-02
EP0349103B1 (en) 1992-11-25
AU3394689A (en) 1989-11-09
PT90466B (pt) 1994-08-31
EP0349103A1 (en) 1990-01-03
AU620866B2 (en) 1992-02-27
JPH01313420A (ja) 1989-12-18
ATE82680T1 (de) 1992-12-15
DE68903605T2 (de) 1993-04-01
IE891414L (en) 1989-11-04
GR3006498T3 (pt) 1993-06-21
NZ228970A (en) 1991-09-25
KR890016963A (ko) 1989-12-14

Similar Documents

Publication Publication Date Title
DK214689A (da) Farmaceutiske midler
ATE125155T1 (de) Niedrigdosierte getrocknete pharmazeutische präparate.
NO922807D0 (no) Farmasoeytiske dideoksypurinnukleosid-preparater til oraltbruk
ATE220321T1 (de) Feste flupirtin enthaltende orale darreichungsformen mit kontrollierter wirkstoffabgabe
ATE215381T1 (de) Pharmazeutische nichtinorganische salzlösungen für endonasale verabreichung eines calcitonins
ES2115616T3 (es) Utilizacion de inositoltrisfosfato en la preparacion de medicamentos.
ATE212550T1 (de) Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung
GB2258397A (en) Pharmaceutical compositions containing amethocaine
MY101266A (en) Pharmaceutical formulations
ATE15139T1 (de) Phosphonomycine pharmazeutische zusammensetzung in tablettenform.
FI904932A7 (fi) Optisesti aktiivisia tiatsetokinoliini-3-karboksyylihappojohdannaisia,menetelmä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia
DE68901852D1 (de) Primycin-loesungen.
IT1213568B (it) Derivati imidazolici adattivita' terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
ATE181828T1 (de) Oral anzuwendendes arzneimittel bestehend aus ibuprofen
SE8303012L (sv) Farmaceutisk komposition

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19940201

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19990831